Sustainable and available sources of omega-3 fatty acids for health: Are the current dietary recommendations, food sources and legislation fit for purpose?

Lewis, Eva, Steenson, Simon, Haslam, Ricahrd P., McDonald, Emma, Sharman, Matthew, Traka, Maria, Stanton, Alice, Napier, Johnathan A., Sweeting, Anna, Saleh, Rasha N. M., Hornberger, Michael, Givens, Ian, Calder, Philip C. and Minihane, Anne Marie (2025) Sustainable and available sources of omega-3 fatty acids for health: Are the current dietary recommendations, food sources and legislation fit for purpose? Nutrition Research Reviews. ISSN 0954-4224

Preview

PDF (Lewis-etal-2025-NRR-AAM) - Accepted Version Available under License Creative Commons Attribution. Download (693kB) | Preview

Abstract

The health benefits of the long-chain omega-3 PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been known for over 50 years and underpin the UK population recommendation to consume > 450 mg EPA+DHA per day. These recommendations, last revised in 2004, are based mainly on epidemiological evidence. Much research has been conducted in the interim. Most RCTs use doses of EPA+DHA of 840 mg per day or more. For anti-inflammatory, triglyceride lowering and anti-hypertensive effects, > 1.5 g EPA+DHA per day is needed. Cognitive benefits are also likely to require these higher intakes. Farmed salmon now contains considerably less EPA+DHA relative to wild-fish, and relative to farmed fish of 20 years ago, meaning one portion per week will no longer provide the equivalent of 450 mg EPA+DHA per day. Oily fish alone can only provide a fraction of the EPA+DHA required to meet global needs. Furthermore, there is low global oily fish consumption, with typical intakes of < 200 mg EPA+DHA per day, and limited intakes in vegans and vegetarians. Therefore, there is an urgent need for affordable, acceptable, alternative EPA+DHA sources, including vegan/vegetarian friendly options, such as bio-enriched poultry, red meat and milk products; fortified foods; enriched oilseeds e.g. genetically modified Camelina sativa; algae and algal oils; and approaches which enhance endogenous EPA/DHA synthesis. In this narrative review we suggest that current EPA+DHA intake recommendations are too low, consider EPA/DHA from a holistic health-sustainability perspective, and identify research, policy and knowledge mobilisation areas which need attention.

Item Type:	Article
Uncontrolled Keywords:	dha,epa,bio-enrichment,brain health,cardiovascular,cognition,fortification,sustainability,nutrition and dietetics,medicine (miscellaneous) ,/dk/atira/pure/subjectarea/asjc/2900/2916
Faculty \ School:	Faculty of Science > School of Biological Sciences Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Mental Health Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Related URLs:	http://www.scopus.com/inward/record.url?... https://www.cambridge.org/core/product/i...
Depositing User:	LivePure Connector
Date Deposited:	30 Jun 2025 12:30
Last Modified:	21 Jul 2025 10:35
URI:	https://ueaeprints.uea.ac.uk/id/eprint/99784
DOI:	10.1017/S0954422425100127

Downloads

Actions (login required)

View Item